Looking beyond HEA: Matching SCD patients for RH variants

BeadChip Molecular Immunohematology: Toward Routine Donor and Patient Antigen Profiling by DNA Analysis

Volumn , Issue , 2011, Pages 101-120

  Reid, Marion E ^a   Hipsky, Christine Halter ^a  

^a NEW YORK BLOOD CENTER   (United States)

Author keywords

Blood groups; DNA microarray; DNA testing; Rh blood group system is the correct ISBT term system; Sickle cell disease

Indexed keywords

EID: 84880349680     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-7512-6_10     Document Type: Chapter

References (68)

1. Aygun B, Padmanabhan S, Paley C et al. (2002) Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 42:37-43
2. Garratty G (1997) Severe reactions associated with transfusion of patients with sickle cell disease. Transfusion 37:357-361
3. Giblett ER (1977) Blood group alloantibodies: an assessment of some laboratory practices. Transfusion 4:299-308
4. Heddle NM, Soutar RL, O'Hoski PL et al. (1995) A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion. Br J Haematol 91:1000-1005
5. Hoeltge GA, Domen RE, Rybicki LA et al. (1995) Multiple red cell transfusions and alloim-munization: experience with 6996 antibodies detected in a total of 159, 262 patients from 1985 to 1993. Arch Pathol Lab Med 119:42-45
6. Redman M, Regan F, Contreras M (1996) A prospective study of the incidence of red cell allo-immunisation following transfusion. Vo x Sang 71:216-220
7. Rosse WF, Gallagher D, Kinney TR et al. (1990) Transfusion and alloimmunization in sickle cell disease. Blood 76:1431-1437
8. Hillyer CD, Shaz BH, Winkler AM et al. (2008) Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services. Transfus Med Rev 22:117-132
9. Adams RJ, McKie VC, Brambilla D et al. (1998) Stroke prevention trial in sickle cell anemia. Control Clin Trials 19:110-129
10. Pegelow CH, Adams RJ, McKie V et al. (1995) Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 126:896-899
11. Vichinsky EP, Luban NL, Wright E et al. (2001) Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 41:1086-1092
12. National Heart, Lung, and Blood Institute (2002) The management of sickle cell disease, NIH Publication # 02-2117 National Institutes of Health, Bethesda, MD http://www.nhlbi.nih.gov/health/prof/blood/sickle/sc-mngt.pdf
13. Giblett ER (1961) A critique of the theoretical hazard of inter vs. intra-racial transfusion. Transfusion 1:233-238
14. Ness PM (1994) To match or not to match: the question for chronically transfused patients with sickle cell anemia. Transfusion 34:558-560
15. Sosler SD, Jilly BJ, Saporito C et al. (1993) A simple, practical model for reducing alloim-munization in patients with sickle cell disease. Am J Hematol 43:103-106
16. Wayne AS, Kevy S V, Nathan DG (1993) Transfusion management of sickle cell disease. Blood 81:1109-1123
17. Tahhan HR, Holbrook CT, Braddy LR et al. (1994) Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 34:562-569
18. Natukunda B, Schonewille H, Ndugwa C et al. (2010) Red blood cell alloimmunization in sickle cell disease patients in Uganda. Transfusion 50:20-25
19. King KE, Shirey RS (2009) Transfusion management of patients with sickle cell disease: the continuing dilemma. Transfusion 50:2-4
20. Olujohungbe A, Hambleton I, Stephens L et al. (2001) Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom. Br J Haematol 113:661-665
21. Reid ME, Lomas-Francis C (2004) Blood group antigen factsbook, 2nd edn. Academic Press, San Diego
22. Roback JD, Combs MR, Grossman BJ et al. (2008) Technical manual, 16th edn. AABB, Bethesda
23. Human Genome Variation Society (2006) Blood group antigen gene mutation database. http://www.ncbi.nlm.nih.gov/gv/mhc/xslcgi.cgi?cmd=bgmut/home. Accessed 30 June 2010
24. Lögdberg L, Reid ME, Lamont RE et al. (2005) Human blood group genes 2004: chromosomal locations and cloning strategies. Transfus Med Rev 19:45-57
25. Lögdberg L, Reid ME, Zelinski T (2010) Human blood group genes 2010: chromosomal locations and cloning strategies revisited. Transfus Med Rev (in press)
26. Daniels GL, Fletcher A, Garratty G et al. (2004) Blood group terminology 2004. Vo x Sang 87:316
27. Baleotti W, Reid ME, Rios M et al (2006) Dombrock gene analysis in Brazilians reveals novel alleles. Vox Sang 91:81-87
28. Banks J, Poole J, Ahrens N et al. (2004) SERF: a new antigen in the Cromer blood group system. Transfus Med 14:313-318
29. Castilho L, Baleotti W Jr, Reid ME et al. (2006) A novel DO allele combination namely DOB-WL. Vox Sang 91(Suppl 3):106
30. Hue-Roye K, Chaudhuri A, Velliquette RW et al. (2005) STAR: a novel high prevalence antigen in the Scianna blood group system. Transfusion 45:245-247
31. Hue-Roye K, Lomas-Francis C, Belaygorod L et al. (2007) Three new high prevalence antigens in the Cromer blood group system. Transfusion 47:1621-1629
32. k phenotype. Immunohematology 23:146-149
33. Rios M, Chaudhuri A, Mallinson G et al. (2000) New genotypes in Fy(a-b-) individuals: nonsense mutations (Trp to stop) in the coding sequence of either FY A or FY B. Br J Haematol 108:448-454
34. Storry JR, Hue-Roye K, Reid ME (2003) A novel PCR assay for the detection of silenced GYPB*S alleles. Transfusion 43(Suppl):1A
35. var phenotype in persons of African descent: implications for transfusion. Transfusion 43:1738-1747
36. Velliquette R, Palacajornsuk P, Hue-Roye K et al. (2008) Novel GYP(A-B-A) hybrid gene in a DANE+ person who made an antibody to a high prevalence MNS antigen. Transfusion 48:2618-2623
37. Singleton BK, Green CA, Avent ND et al. (2000) The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood 95:12-18
38. Tournamille C, Colin Y, Cartron JP et al. (1995) Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 10:224-228
39. Castilho L et al (1998) Duffy genotyping in Fy(b) Brazilians and the prevalence of the GATA box mutation. Transfusion 38(Suppl):38S
40. b-GATA and RHD in a population of highly diverse ancestry [Abstract]. Transfusion 39(Suppl 1):104s
41. Rios M, Reid ME, Naime D et al. (1997) Importance of GATA box analysis in genotyping for the Duffy blood group system [Abstract]. Transfusion 37(Suppl):101S
42. Storry JR, Sausais L, Roye-Hue K et al. (2003) GUTI: a new antigen in the Cromer blood group system. Transfusion 43:340-344
43. Avent ND, Martinez A, Flegel WA et al. (2007) The BloodGen project: toward mass-scale comprehensive genotyping of blood donors in the European Union and beyond. Transfusion 47:40S-46S
44. Beiboer SH, Wieringa-Jelsma T, Maaskant-Van Wijk PA et al. (2005) Rapid genotyping of blood group antigens by multiplex polymerase chain reaction and DNA microarray hybridization. Transfusion 45:667-679
45. Bugert P, McBride S, Smith G et al. (2005) Microarray-based genotyping for blood groups: comparison of gene array and 5¢-nuclease assay techniques with human platelet antigen as a model. Transfusion 45:654-659
46. Denomme GA, Van Oene M (2005) High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes. Transfusion 45:660-666
47. Westhoff CM (2006) Molecular testing for transfusion medicine. Curr Opin Hematol 13:471-475
48. Hashmi G, Shariff T, Seul M et al. (2005) A flexible array format for large-scale, rapid blood group DNA typing. Transfusion 45:680-688
49. Hashmi G, Shariff T, Zhang Y et al. (2007) Determination of 24 minor red blood cell antigens for more than 2000 blood donors by high-throughput DNA analysis. Transfusion 47:736-747
50. Klapper E, Zhang Y, Figueroa P et al. (2010) Toward extended phenotype matching: a new operational paradigm for the transfusion service. Transfusion 50:536-546
51. Shaz BH, Zimring JC, Demmons DG et al. (2008) Blood donation and blood transfusion: special considerations for African Americans. Transfus Med Rev 22:202-214
52. Ribeiro KR, Guarnieri MH, da Costa DC et al. (2009) DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease. Vox Sang 97:147-152
53. Wagner FF, Frohmajer A, Flegel WA (2001) RHD positive haplotypes in D negative Europeans. BMC 2:10
54. Avent ND, Reid ME (2000) The Rh blood group system: a review. Blood 95:375-387
55. Wagner FF, Flegel WA (2000) RHD gene deletion occurred in the Rhesus box. Blood 95:3662-3668
56. Westhoff CM (2007) The structure and function of the Rh antigen complex. Semin Hematol 44:42-50
57. Huang C-H, Liu PZ, Cheng JG (2000) Molecular biology and genetics of the Rh blood group system. Semin Hematol 37:150-165
58. Noizat-Pirenne F, Lee K, Le Pennec P-Y et al. (2002) Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood 100:4223-4231
59. Vege S, Meyer W, Copeland T et al. (2007) A new RHce allele, RHCE*ceTI, is associated with C typing discrepancies and is linked to RHD*DIVa. Transfusion 47(Suppl):156A-157A
60. Hemker MB, Ligthart PC, Berger L et al. (1999) DAR, a new RhD variant involving exons 4, 5, and 7, often in linkage with ceAR, a new Rhce variant frequently found in African blacks. Blood 94:4337-4342
61. B-red cell phenotype [Abstract]. Transfusion 47(Suppl):155A-156A
62. Westhoff CM, Vege S, Halter-Hipsky C et al. (2010) DIIIa and DIII type 5 are encoded by the same allele and are associated with altered RHCE*ce alleles: clinical implications. Transfusion 50:1303-1311
63. Lomas-Francis C, Reid ME, Westhoff C et al. (2009) JAL (RH48) blood group antigen: sero-logical observations. Transfusion 49:719-724
64. Halter Hipsky C, Lomas-Francis C, Fuchisawa A, et al. (2010) RHCE*ceCF encodes partial c and partial e but not CELO an antigen antithetical to Crawford. Transfusion (in press)
65. Westhoff CM, Anstee DJ (2010) A new paradigm for pretransfusion testing with the same perennial limitations. Transfusion 50:520-521
66. Halter-Hipsky C, Hue-Roye K, Coghlan G et al. (2009) Two alleles with RHCE*nt818C>T change encode the low prevalence Rh antigen STEM. Blood 114(Suppl):1226-1227
67. Reid ME (2009) Applications and experience with PCR-based assays to predict blood group antigens. Transfus Med Hemother 36:168-178
68. Strauss D, Reid ME (2008) Value of DNA-based assays for donor screening and regulatory issues. Immunohematology 24:175-179